OxTalks is Changing
            
                On 28th November OxTalks will move to the new Halo platform and will become 'Oxford Events' (full details are available on the Staff Gateway).
            
            
                There will be an OxTalks freeze beginning on Friday 14th November. This means you will need to publish any of your known events to OxTalks by then as there will be no facility to publish or edit events in that fortnight. During the freeze, all events will be migrated to the new Oxford Events site. It will still be possible to view events on OxTalks during this time.
            
            
                If you have any questions, please contact halo@digital.ox.ac.uk
            
         
     
 
            
            
On the role of the microbiota as a key modulator of the tumor microenvironment
    
	Cancer has historically been viewed as a disease determined by genetic and environmental factors, however, it is now clear that inflammation affects all stages of the disease: initiation, progression and metastasis formation. The inflamed tumor microenvironment is in part sustained by infiltrating mononuclear phagocytes (MPs) [e.g. dendritic cells, monocytes, macrophages] and neutrophils. In cancer, as in infection, MPs can induce adaptive immune responses, but in cancer they mainly promote the tumor’s immune evasion, progression, and metastasis. We, and others, have recently uncovered a role for commensal microbes in controlling the response of subcutaneous tumors to cancer immuno- and chemotherapy. In this presentation, we will discuss the role of the microbiota in regulating the composition and function of the myeloid cell compartment in the tumor microenvironment and the role of these cells in the response to cancer chemotherapy. Targeting MPs represents a powerful approach to manipulate the outcome of immune responses; therefore, a clear understanding of their regulation and functional organization may lead to rational novel cancer immunotherapeutic approaches.
Date:
26 July 2017, 15:00
Venue:
  Old Road Campus Research Building, Headington OX3 7DQ
  
Venue Details:
  Ludwig Seminar Room, Basement ORCRB
  
Speaker:
  
    Dr Romina Goldszmid (NIH)
  
    
Organising department:
    Ludwig Institute for Cancer Research, Oxford Branch
    
Organiser:
    
        Christina Woodward (Oxford Ludwig Institute, Nuffield Department of Medicine, University of Oxford)
    
    
Host:
    
        Professor Len Seymour (University of Oxford)
    
    
Part of:
    Ludwig Institute Seminar Series
Booking required?:
Not required
Audience:
Members of the University only
    
Editor: 
      Christina Woodward